Cardiotoxicity in Breast Cancer Patients
NCT06491680
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Dapagliflozin 10mg Tab
Sponsor
Helwan University